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Purpose: Arteriovenous malformations are often treated with a combination of embolization and
stereotactic radiosurgery. Concern has been expressed in the past regarding the dosimetric properties
of materials used in embolization and the effects that the introduction of these materials into the brain
may have on the quality of the radiosurgery plan. To quantify these effects, the authors have taken
large volumes of Onyx 34 and Onyx 18 (ethylene-vinyl alcohol copolymer doped with tantalum) and
measured the attenuation and interface effects of these embolization materials.
Methods: The manufacturer provided large cured volumes (∼28 cc) of both Onyx materials. These
samples were 8.5 cm in diameter with a nominal thickness of 5 mm. The samples were placed on a
block tray above a stack of solid water with an Attix chamber at a depth of 5 cm within the stack.
The Attix chamber was used to measure the attenuation. These measurements were made for both 6
and 16 MV beams. Placing the sample directly on the solid water stack and varying the thickness of
solid water between the sample and the Attix chamber measured the interface effects. The computed
tomography (CT) numbers for bulk material were measured in a phantom using a wide bore CT
scanner.
Results: The transmission through the Onyx materials relative to solid water was approximately
98% and 97% for 16 and 6 MV beams, respectively. The interface effect shows an enhancement
of approximately 2% and 1% downstream for 16 and 6 MV beams. CT numbers of approximately
2600–3000 were measured for both materials, which corresponded to an apparent relative electron
density (RED) ρwe to water of approximately 2.7–2.9 if calculated from the commissioning data of
the CT scanner.
Conclusions: We performed direct measurements of attenuation and interface effects of Onyx 34
and Onyx 18 embolization materials with large samples. The introduction of embolization materials
affects the dose distribution of a MV therapeutic beam, but should be of negligible consequence for
effective thicknesses of less than 8 mm. The measured interface effects are also small, particularly
at 6 MV. Large areas of high-density artifacts and low-density artifacts can cause errors in dose
calculations and need to be identified and resolved during planning. © 2012 American Association of
Physicists in Medicine. [http://dx.doi.org/10.1118/1.4757918]
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I. INTRODUCTION
Cerebral arteriovenous malformations (AVMs) represent a
cluster of abnormal arterioles, veins, and the interconnecting
nidus without intervening cerebral tissue or capillary beds.
Cerebral AVMs have a prevalence of 19 per 100 000 pa-
tient years as reported by Brown et al.1 While AVMs can
cause headaches, seizures, and ischemia, most commonly
they present with intracranial hemorrhage. Cerebral AVM as-
sociated hemorrhage carries significant morbidity (40%) and
mortality (12%).2 The goal of any treatment modality is to
cause obliteration of the nidus thus preventing hemorrhage
and associated complications.
Treatment of cerebral AVMs relies on a multimodality ap-
proach, which includes microsurgical resection, radiosurgery,
and/or endovascular embolization. Endovascular techniques
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aim at preventing flow through a cerebral AVM by introduc-
ing embolization material within the nidus. While the flow
may only diminish in most instances, smaller AVMs with few
feeders can be cured with this technique.3 Two commonly
used materials for cerebral AVM embolization are Onyx
(ethylene-vinyl alcohol co-polymer (EVOH))and n-BCA
(n butyl cyanoacrylate).4
Onyx is a commercial embolic agent consisting of a mix-
ture of EVOH doped with micronized tantalum, which is sus-
pended in a dimethyl sulfoxide (DMSO) carrier. The Onyx
EVOH material is doped with tantalum (z = 73) to aid visu-
alization during cerebral angiography. Onyx agents come in
viscosities of 18, 20, and 34 centistokes (mm2/sec), the vis-
cosities are achieved by changing the fraction of EVOH in the
agent; the percentage of EVOH is 6%, 6.5%, and 8%, respec-
tively, for the available viscosities. These forms of the Onyx
material are referred to as Onyx 18, Onyx 20, and Onyx 34,
respectively. Mamalui-Hunter et al.5 have concluded the con-
centration of tantalum in a sample of Onyx 34 they analyzed
was 0.0784 ± 0.012 g/cm3.
Onyx is not “glue” as it has no actual adhesive properties.
Instead solidification occurs when an Onyx agent contacts flu-
ids, such as blood or other body fluids. The EVOH precipi-
tates and the DMSO carrier flows out of the precipitated mass
leaving the precipitated mass in place. The lower viscosity
material is considered appropriate for use in larger malforma-
tions since it will penetrate more distally from injection, while
the high viscosity material is appropriate for use to block ar-
eas of higher flow in larger vessels. Final solidification occurs
within 5 min for Onyx agents.
A number of publications have reported lower obliteration
rates and reduced success rates of patients treated with ra-
diosurgery who have been embolized prior to treatment.6–9
Onyx may allow for a more complete occlusion of the AVM
nidus based on its physical properties when compared with
n-BCA. However, there are concerns that the tantalum visu-
alization agent within the embolic material may have an ef-
fect on the efficacy of the treatment for those brain AVMs
treated by radiosurgery. Tantalum causes significant artifacts
on computed tomography (CT) exams and may make target-
ing of the lesion with radiosurgery difficult. In addition, tan-
talum has an atomic number (Z = 73), which highly attenu-
ates the radiation at diagnostic energies. Other embolization
materials such as n-BCA use iodine (Z = 53) as a visualiza-
tion material during injection. The conjecture has been that
the high Z imaging material, tantalum or iodine, may also
cause high attenuation at therapeutic energies causing errors
in dose calculations, which could lead to less than optimal ra-
diosurgery plans. If true, these suboptimal plans could be less
efficacious in damaging the angioarchitecture of the AVM.
Concerns have been expressed in the past regarding the dosi-
metric properties of embolizing agents such as Onyx and the
effects that the introduction of these agents into the brain may
have on the quality of the radiosurgery plans on based on this
argument.10, 11 A previous group has published results show-
ing that dose deposition is not significantly affected by the
presence of the embolization material for Gamma Knife treat-
ments, which use 60Co treatment beams.5, 12 Other direct mea-
surements of attenuation constants for this embolization ma-
terial have been done with small volumes (∼1.5 cc) and with
pinpoint chambers13 or in-phantom measurements,14 which
may lead to problematic results due to the small sample sizes
involved.
II. METHODS AND MATERIALS
The presence of visualization material during CT scans
produces both bright regions of high absorption (high CT
numbers) and dark regions of low absorption (low CT num-
bers). These areas correspond to regions of apparent high
electron density and apparent low electron density, respec-
tively. The resulting artifacts, which may obscure the adjacent
target areas, cause delineation of target structures and dose
calculations to become highly problematic. Figure 1 shows a
1 mm slice of a CT from an AVM patient that was embolized
using Onyx 18 material. This figure illustrates CT artifacts
due to the high Z visualization material both in the immediate
region of the embolization and well removed from that region.
Additionally the question arises as to whether the presence of
areas with high absorption in a CT scan made at kilovolt en-
ergies implies high dose deposition and attenuation at thera-
peutic energies in those same areas.
We made measurements of effective linear attenuation of
bulk material, interface effects at therapeutic energies, CT
numbers at diagnostic energies and performed model calcula-
tions of typical artifacts. The effective linear attenuation was
measured relative to solid water to determine whether the em-
bolization material affects dose deposition downstream from
FIG. 1. The image above shows a 1 mm thick CT slice from a patient that
had AVM embolization prior to SRS. Note the large artifacts caused by the
tantalum powder infused into the embolization material to aid visualization.
These artifacts could lead to large errors in dose calculations and obscure
the target region making correct delineation of target volumes extremely
problematic.
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the material. The interface effect was measured to determine
if the presence of embolization material creates dose differ-
ences at the interface of the embolization material and the
surrounding material. CT numbers were measured to estab-
lish the effect that the embolization material has on the ap-
parent electron densities that are used in dose calculations
both within the target region and in regions affected by arti-
facts created by the embolization material. Model calculations
were made based on the measured CT numbers to illustrate
dose errors created by incorrectly assigned apparent electron
densities.
The properties of the embolization material were measured
in bulk, since that represents a worst-case scenario. In actual
use, the material forms an admixture of tissue and emboliza-
tion material when it is injected. Neither the density nor exact
composition of this admixture can be known, thus we have
chosen to measure the effective linear attenuation of the bulk
material, which then can be used as an upper limit for the
linear attenuation of the in vivo admixture of tissue and em-
bolization material.
To quantify these effects we have taken two large vol-
umes of Onyx material and measured the attenuation and in-
terface effects of these embolizing agents at linear acceler-
ator (Linac) energies of 6 and 16 megavolts (MV). For this
study we received from the manufacturer (EV3 Neurovascu-
lar, Irvine, California) a large volume (∼28 cm3) cured sam-
ple of Onyx 34 and a second cured sample of the same volume
of Onyx 18. These cured samples of the materials were 8.5 cm
in diameter with a nominal thickness of 5 mm. The nominal
thickness of the material was measured after the attenuation
measurements were made. These large samples allowed direct
measurements of both attenuation of MV treatment beams
and interface effects using a Varian 2100 EX (Varian, Palo
Alto, California) Linac at both 6 and 16 MV. For stereotac-
tic radiosurgery (SRS) treatments only 6 MV beams are used
clinically in our institution. The additional measurements at
16 MV were made for comparison of the attenuation proper-
ties of the material across typical energies available on clinical
linear accelerators.
II.A. Effective linear attenuation measurements
For the attenuation measurements the samples were placed
on a block tray in the accessory mount of the treatment Linac.
A phantom was placed on the treatment couch below the ac-
cessory mount. The phantom consisted of a stack of solid wa-
ter with a source to surface distance (SSD) of 95 cm with
an Attix chamber at a depth of 5 cm, as a result the top
surface of the Attix chamber was at the machine’s isocenter
(100 cm). There was 11 cm of solid water below the Attix
chamber to provide backscatter. The geometry for this mea-
surement is shown in Fig. 2. The depth of 5 cm was chosen
to avoid making measurements in buildup regions for both
beams, which could lead to problematic interpretation of the
results. For normalization, the sample was replaced with a
5 mm piece of solid water and the same measurements were
repeated. By placing the samples on the block tray it was pos-
sible to use field sizes of up to 20 × 20 cm2. Each measure-
FIG. 2. The experimental setup used to measure the effective attenuation
coefficients of the Onyx material. The sample material was placed on a block
tray in the accessory head of the Linac. The phantom had a cross section of
40 × 40 cm2 with a depth of 18 cm that provided 11 cm of backscatter below
the Attix chamber.
ment was repeated five times. Estimated errors for these nor-
malized transmission measurements were calculated from the
standard deviation of dose measurements which were added
in quadrature for the Onyx material and the solid water.
The effective attenuation constant was found by assum-
ing that the transmission (T) for material thickness x can be
written as
T = e−μeffx, (1)
where μeff is the effective attenuation constant. This effective
attenuation constant was determined by inverting Eq. (1) to
yield the following equation:
μeff = − ln(T )
x
. (2)
In Eqs. (1) and (2), T is the transmission of the material of
thickness x. The transmission was measured for both the solid
water and onyx embolization material by exposing the Attix
chamber in the solid water stack, as described previously, to
200 monitor units with and without the material on the block
tray. The transmission was calculated as the ratio of the dose
measurements with the sample material on the block tray to
the dose measurements with no material on the block tray.
Measurements were made of the effective attenuation con-
stant as a function of field size.
Errors in the effective attenuation constants were estimated
by cutting each of the samples across the diameter of the sam-
ple in order to measure the sample thickness along the cut line
with a pair of vernier calipers. A mean thickness and standard
deviation of the material thickness were calculated from these
data. The mean thickness was used as the value of x in Eq. (2).
The probable errors in the effective attenuation constants were
estimated as errors associated with the measurement of T and
measurement of x summed in quadrature:
σ (μ) =
√√√√((σ (T )
xT
)2
+
(
ln(T )σ (x)
x2
)2)
, (3)
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where σ (T) is the standard deviation of the measured nor-
malized transmission as described previously and σ (x) is the
standard deviation of the thickness of the Onyx material de-
termined from measurements.
To model the dose differences caused by inclusion of this
embolization material in a therapy beam the following model
was developed based on the measured effective attenuation
constants. Estimates were made by taking the measured at-
tenuation coefficients for Onyx 34 at 6 MV and calculating
the dose deposition difference at the distal edge of the em-
bolizing material when that material was replaced by water
while leaving the geometric distance, and hence the inverse
square law, invariant. The calculations were water blocked.
These errors are relative to water and not brain material and
represent the error for a single beam which transits the em-
bolizing material. The estimates of the probable errors were
calculated by replacing the value of the attenuation coeffi-
cient with the mean value plus and minus one standard de-
viation. We note that this model accounts only for the loss of
fluence due to the increased attenuation of the material and
does not consider other factors such as change in scattering in
the calculations, which would require extensive Monte Carlo
calculations.
II.B. Interface effects
The interface effects were measured with an Attix cham-
ber by placing the sample directly on the solid water stack
and increasing the thickness of solid water between the sam-
ple and the Attix chamber by adding slabs of solid water one
at a time while keeping the SSD to the top of the solid water
stack constant at 95 cm and delivering 200 monitor units. The
SSD of the stack was set with a front pointer after each addi-
tion of a solid water slab. The interface effect was measured
for a 5 × 5 cm2 field. A schematic drawing representing the
setup used for the interface effect measurements is shown in
Fig. 3. Replacing the embolization material with a 5 mm slab
of solid water and repeating the measurement procedure nor-
malized the measurements. The measurements were repeated
five times for each depth of the embolization material and the
FIG. 3. Schematic representation of the experimental setup used to measure
the interface effect of the Onyx embolization material. The Onyx sample ma-
terial was placed directly on the top of the phantom and the thickness of the
material between the Onyx sample and the Attix chamber was varied. The
SSD was held constant for all measurements. The measurements were nor-
malized to solid water by repeating the measurement with the Onyx sample
replaced by a 5 mm thick piece of solid water.
solid water. The ratio R(x) (in percent) was then calculated as
a function of the thickness x of the solid water between the
sample and the Attix chamber as
R(x) =
[
DOnyx(x)
DSW(x)
]
× 100, (4)
where DOnyx(x) is the dose deposited at a depth of x with the
Onyx sample on top of the phantom and DSW(x) is the dose
deposited at a depth of x with the 5 mm piece of solid water
replacing the Onyx on top of the solid water phantom.
The interface effect at a depth of x (IE(x) in percent) from
the Onyx sample was calculated as
IE(x) = (R(x) − 100). (5)
The difference (in percent) calculated in Eq. (4) was inter-
preted as being caused by the replacement of the solid water
with the embolization material at the interface, and thus due
to the embolization material.
The errors for the interface effect were estimated by adding
the standard deviations of the measurements of the dose for
the Onyx material and solid water in quadrature.
II.C. Measurements of CT numbers
for embolization materials
The radio-density of material measured in a CT scanner is
measured in Hounsfield units, which are given by the follow-
ing equation for material type denoted by y:
HU(y) = 1000(μy − μwater)
μwater
. (6)
Equation (6) can be inverted to calculate the linear attenuation
coefficient at the diagnostic energy of measurements of the
material as follows:
μy = (HU(y) + 1)1000 μwater, (7)
where μy and μwater are the linear attenuation coefficients of
material y and water, respectively, in Eqs. (6) and (7). It is
important to note, however, that the linear attenuation coef-
ficient calculated in Eq. (7) is for the diagnostic energies used
in the CT scan and not for the therapeutic energies used for
treatment. Additionally, CT scanners do not accurately pre-
dict electron densities for high Z material, but over respond15
creating artifacts.16–21
CT numbers were measured using a Philips Brilliance
(Koninklijke Philips Electronics, Amsterdam, The Nether-
lands) large bore 85 cm 16 slice CT scanner. The scanner CT
numbers were calibrated to electron density using a Gammex
467 CT phantom (Gammex Inc. Middleton, WI) for CT num-
bers from –790 (120 kVp, LN-300 Lung phantom material)
up to 1565 (120 kVp, cortical bone phantom material). The
relative electron density (RED) was calculated by extrapola-
tion from the clinical CT number to electron density curve
used for treatment planning, which was determined during the
commissioning of the scanner.
For these measurements samples of embolization material
were placed between two pieces of solid water 5 cm thick with
a 30 × 30 cm2 cross section to mimic an in vivo scan. This
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FIG. 4. Schematic representation of the placement of the region of interest
(ROI) used to calculate the CT numbers of the Onyx samples. The sample
was placed between two 30 × 30 cm2 solid water slabs, shown above as
dark material, the sample is shown as the lighter material. This phantom was
scanned as described in the text. The region of interest was placed in the
plane of the sample such that it was parallel to the surfaces of the sample and
surfaces of the solid water slabs. The ROI was circular in the coronal plane
as shown. The size of the ROI shown is exaggerated for clarity.
phantom was scanned with techniques of 90 kVp, 120 kVp,
and 140 kVp with 1 mm thick CT slices. A circular region of
interest (ROI) 1 cm in diameter was placed in the middle of
the embolization material in the plane parallel to cross section
of the material that appeared to be most centrally located rel-
ative to the thickness of the embolization material. Figure 4
illustrates the placement of the ROI used to measure the CT
numbers in the samples. This assured that the region of inter-
est used to calculate the CT numbers was not at the edge of the
material and was therefore less likely to be affected by edge
artifacts caused by the material. The software on the scanner
was used to determine the mean values and the standard devi-
ations of the CT numbers.
II.D. Phantom calculations
The presence of high Z material, such as the Onyx em-
bolization material, causes both high-density and low-density
artifacts in CT scans. These artifacts are commonly seen
with patients that have metal fillings in their teeth, hip or
knee replacements, surgical clips, prostate seed implants, im-
plantable cardiac devices and the leads to those devices to
name just a few.16–21 A consequence of these artifacts is that
the electron density calculated from the CT numbers within
the regions of these artifacts in incorrect. This incorrect as-
signment of electron densities can significantly affect the
quality of the dose calculations in these regions. In order to
investigate the consequences of these artifacts on treatment
plans of patients that have had embolization of their AVMs
prior to obtaining the planning CT a simple mathematical
phantom was constructed using the in house planning system,
UMPlan at the University of Michigan.
FIG. 5. Schematic representation of the mathematical phantom used for the
model calculations. The main phantom was 10 cm thick with a cross sec-
tion of 15 × 15 cm2. The three structures indicated had cross sections of
10 × 10 cm2 and thicknesses of 5 mm. These structures could have their rel-
ative electron density assigned independently. The rest of the material had an
electron density equal to water assigned. All the material had a mass density
equal to water assigned. The drawing is not to scale, the variable structures
have been drawn excessively thick for ease of viewing. All relevant dimen-
sions are indicated on the drawing.
The model phantom was 10 cm thick with a cross section
of 15 × 15 cm2. The purpose of this phantom was to allow
modeling of the effects of the artifacts created by the em-
bolization agent on dose deposition calculations. Within the
phantom three additional mathematical structures were de-
fined each 5 mm thick with a cross section of 10 × 10 cm2
such that the cross section for each structure was paral-
lel to the cross section of the larger phantom, as shown in
Fig. 5. Each of these structures formed a thin “slab” within
the phantom. The phantom had a SSD of 95 cm. The top
of the first structure was 4.25 cm below the surface of the
main phantom, 99.25 cm from the source. The two remain-
ing structures had their top surfaces at 99.75 and 100.25 cm,
respectively. The center of the second slab was at isocen-
ter, and the first and second slab could simulate material
either proximal or distal to isocenter. The electron density
of each slab structure could be assigned before calculation.
The mass density was set to 1 g/cm3 for these slab struc-
tures and the rest of the phantom. The portions of the phan-
tom outside these three structures were assigned an electron
density equal to water. This model is meant to demonstrate
errors associated with artifacts caused by the embolization
material independent of the errors caused by the material
itself.
For these calculations a 3 × 3 cm2 6 MV beam was de-
fined such that the central ray passed through the phantom and
each structure. The dose calculations used 1 mm grid spacing.
Though there are many variations of electron density that can
be calculated, five cases were chosen. The relative electron
densities to water for the five model geometries chosen are
given in Table II.
Geometry 1 is the baseline geometry where a 5 mm thick
AVM is at isocenter with no artifacts surrounding it. The
apparent electron density acquired from CT scans was as-
signed to the middle slab structure. The second geometry was
meant to model a high-density artifact proximal to the AVM
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FIG. 6. The transmission relative to solid water for a 16 MV beam (upper curves) and 6 MV beam (lower curves) as a function of the field size. The beam
energy (in MV) and material type are indicated in the legend. The error bars indicate one standard deviation and were calculated as indicated in the text.
followed by a low-density artifact distal. The third geome-
try was meant to approximate Onyx material with a distal
high-density artifact followed by a low-density artifact. The
fourth geometry had all structures assigned an electron den-
sity of water. This geometry was meant to simulate a water-
blocked calculation, where the densities of any embolization
material and associated artifacts were overridden. The last
geometry was meant to approximate a case where the em-
bolization material volume was correctly identified with the
apparent electron density assigned from the CT scan followed
by a low-density artifact downstream of the embolization
material.
III. RESULTS
III.A. Effective linear attenuation measurements
The results of the measurements of the transmission of 6
and 16 MV beams, normalized to 5 mm solid water, are shown
in Fig. 6 for both Onyx 18 and Onyx 34. The relative trans-
missions were approximately 98% for 16 MV and 97% for
6 MV treatment beams. The error bars in Fig. 4 were calcu-
lated, as described in Sec. II.A, from the standard deviations
of the measured doses for the Onyx material and solid water.
The effective linear attenuation coefficients calculated
from Eq. (2) are shown in Fig. 7. The error bars in Fig. 7
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FIG. 7. The effective linear attenuation constants of solid water (bottom two curves) and the Onyx embolization materials at 6 and 16 MV. The data legend to
the right of the figure indicates the energy of the beam (in MV) and the type of Onyx material. The error bars indicate one standard deviation and were calculated
as indicated in the text.
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FIG. 8. The probable dosimetric error for a 6 MV beam as a function of the
effective thickness of the embolizing material relative to water for a single
beam. The dashed lines represent the errors calculated by replacing the ef-
fective linear attenuation constant with the mean plus or minus one standard
deviation.
were estimated from Eq. (3). Figure 7 indicates that effective
attenuation constants for the two embolizing materials were
∼3–4 times higher than effective attenuation constants for
solid water at both 6 and 16 MV. This indicates that this em-
bolization material does introduce additional attenuation. At
an effective thickness of 5 mm the attenuation of the Onyx
material is approximately 2% higher for 16 MV and 3%
higher for 6 MV than the attenuation of solid water.
The results of the model dose difference calculations are
shown in Fig. 8. Probable errors are shown in Fig. 8 by dashed
lines above and below the calculation line. There are two
points to note from this figure: first, the model reproduces
the transmission measurement shown in Fig. 4; secondly, the
errors appear linear with thickness because the thicknesses
shown in the figure are small compared to 1/μeff causing the
exponential nature of the attenuation to appear linear in the
displayed range.
III.B. Interface effects
Figure 9 shows the results of the interface measurements
for Onyx 34; the results for Onyx 18 are similar. Figure 9(a)
shows the results of the measurements of the interface effect
on Onyx 34 for a 6 MV beam. The vertical axis represents
the excess, or deficit, when the sample is replaced with a
5 mm thick slab of solid water. The inset in Fig. 9(a) shows
an expanded view for depths from 0 to 20 mm of the interface
effect of a 6 MV beam to better illustrate the effect at small
distances. Figure 9(b) shows the results for a 16 MV beam.
From these figures it is apparent that at 16 MV there does ap-
pear to be a small interface effect on the order of 2% in the
first 10 mm. For 6 MV, the dose is apparently enhanced at the
interface by about 1%, but the magnitude of the interface ef-
fect is approximately equal to the measurement uncertainty. If
any real positive interface effect exists at 6 MV it is probably
limited to not more than 5 mm and has a magnitude of less
than 1%. At 6 MV an apparent deficit of approximately 0.5%
in the region from 10 to 50 mm is seen. This deficit was repro-
ducible over a number of experiments. No similar deficit was
measured for the 16 MV beam; the interface effect decreases
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FIG. 9. Graph (a) shows the results of the measurements of the interface ef-
fect on Onyx embolization materials for 6 MV beam. The inset in the corner
shows an expanded view of the measurements for depths between 0 mm and
20 mm to better illustrate the interface effect for a 6 MV beam. Graph
(b) shows the results of measurements for a 16 MV beam. The interface effect
was calculated as the ratio of the dose deposited in an Attix chamber at the
indicated depth below the Onyx material and below a 5 mm slab of solid wa-
ter, respectively. A field size of 5 × 5 cm2 was used for these measurements.
For each measurement the SSD was kept constant. The error bars indicate
one standard deviation and were calculated as indicated in the text.
to zero, within experimental uncertainty, at approximately
20 mm below the material for this higher beam energy.
III.C. CT number measurements
Table I shows the results of the measurements of CT num-
bers and the value ρwe for the electron density relative to water.
As noted in Sec. II.C high Z materials cause the CT scan-
ners to over-respond. This over-response coupled with the in-
herent errors associated with the extrapolation of CT num-
bers to high HU results in values of ρwe for the embolizing
agents which are un-physically high. The high values of the
CT numbers measured in the CT scanner and the physical size
of the samples created bright artifacts in the portions of the
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TABLE I. Measured CT numbers and calculated electron density relative to water (ρwe ) for Onyx materials. The
relative electron densities were calculated using the clinical CT number to electron density curve which was
determined during the commissioning of the CT scanner and are excessively high.
Measured CT numbers ρwe
Technique (kVp) Onyx 34 Onyx 18 Onyx 34 Onyx 18
90 2950 ± 246 2685 ± 230 2.86 ± 0.239 2.69 ± 0.230
120 2975 ± 268 2615 ± 221 2.84 ± 0.256 2.65 ± 0.224
140 2997 ± 279 2685 ± 249 2.89 ± 0.269 2.71 ± 0.252
phantom slabs that were either directly above or below the
sample. These bright artifacts essentially affected all portions
of the phantom material on slices where the Onyx material
was present.
III.D. Phantom model calculations
To compare the results of the five model phantom calcula-
tions described in Sec. II, the ratio of cases 2–5 was formed
by dividing the computed dose on the central axis by the com-
puted dose from geometry 1. The results are seen in Fig. 10.
The first point to note from this figure is that the water-
blocked calculation, geometry 4, actually has the largest de-
viations from geometry 1. Secondly, the major errors in the
dose calculations do not necessarily occur near high-density
structures, but rather propagate downstream several centime-
ters and become nearly constant at a distance of ∼3 cm down-
stream of these structures. Geometry 5, which is closest to ge-
ometry 1, has the smallest deviations. Geometries with large
low-density regions tend to show excess dose downstream
because the attenuation of the material has been underesti-
mated. Likewise, the model with the largest high-density ar-
tifact, geometry 3 shows a deficit of dose downstream due
to the overestimate of the attenuation caused by the apparent
high-density region of the artifact. These calculations show
quickly the consequences that both high- and low-density ar-
tifacts caused by the embolization material can have on dose
calculations algorithms. Care must be exercised to assure that
the dose calculations will not be adversely affected by the
presence of artifacts in planning CT scans.
IV. DISCUSSION
From Fig. 6 it is seen that for an effective embolizing mate-
rial thickness of 5 mm, the dose difference between solid wa-
ter and Onyx material is 2% and 3% for 16 and 6 MV beams,
respectively. The embolization material does show a greater
linear attenuation coefficient than solid water, as can be seen
in Fig. 7 where μeff increases by about a factor of three for the
embolization material relative to solid water at therapeutic en-
ergies. Due to the increase in the linear attenuation coefficient
for the Onyx material the dosimetric differences can become
significant (>5%) for beams which encounter effective mate-
rial thickness greater than 8–10 mm as seen in Fig. 8. Thus
for beams passing through large amounts of embolizing ma-
terial, greater than 8 mm of effective thickness, a correction
to monitor units may be required if the target is distal to the
Onyx material.
The treatment of AVMs using SRS is generally limited to
malformations where the maximal size is usually less than
FIG. 10. The ratio of dose deposition for the four geometries divided by the baseline geometry as discussed in the text with the parameters given in Table II.
The lines represent the errors, which may be caused by incorrect assignment of electron densities caused by CT artifacts in the planning scan.
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TABLE II. Electron densities relative to water (ρwe ) used in phantom model structures for model calculations and simulation purposes as described in the text.
ρwe
Phantom structure number
Geometry 1 2 3 Purpose of simulation
1 1 2.9 1 AVM volume with electron density from assigned CT scan
2 2.9 0.001 0.001 Low-density artifact distal to AVM
3 2.9 2.9 0.001 High and low-density artifacts surrounding AVM
4 1 1 1 Water blocked calculation
5 1 2.9 0.001 Low density artifact distal to AVM
3 cm in any dimension.22–24 However, the exact nature of the
angioarchitecture of each AVM is unique, so it is not possible
to estimate a priori the effective thickness of the embolizing
material within an AVM. This is a clinical decision that will
have to be discussed at the time of treatment, first to decide if
monitor units corrections are needed, and secondly to make a
clinical estimate of the effective thickness of the embolizing
material seen by each treatment beam.
The measured interface effects shown in Fig. 9 are not sig-
nificant (<1%) for 6 MV; while a small enhancement of ∼2%
or less is seen at 16 MV. This effect is limited to about 20 mm
for the higher energy beam. The curve seen in Fig. 9(a) for the
6 MV beam shows a tantalizing hint of interesting physics.
There may be two competing processes in place, which may
cause the observed behavior. First the presence of the high Z
tantalum will increase Compton scattering in the emboliza-
tion material creating a small increase of dose close to the
interface. This may be competing with the increased atten-
uation which removes photon fluence from the beam down-
stream, and thus is responsible for the apparent dose deficit
just beyond the interface. In this model the higher energy
16 MV beam should scatter even more electrons toward the
interface, while the lower attenuation (∼1%) of the 16 MV
beam could be just enough to account for the lack of dose
deficit beyond 10 mm as seen in Fig. 9(b), as the higher en-
ergy beam is less attenuated as seen in Fig. 6. Confirmation
of this theory would require significant Monte Carlo calcu-
lations, which are beyond the scope of this paper. However,
this theory does seem to conform to the physics and quali-
tatively explain the results. We conclude however, that any
interface effect at 6 MV is small and can be ignored for treat-
ment beams.
Figure 1 shows a 1 mm slice of a CT from an AVM patient
that was embolized using Onyx 18 material. Note the high
CT numbers in the area of the embolization as well as the ar-
eas of both high and low CT numbers due to artifacts caused
by the embolization material. These artifacts arise from the
high CT numbers of the Onyx material, as indicated in
Table I. These artifacts are very likely to obscure the treatment
volume, making accurate definition of treatment volume prob-
lematic at best. To establish target volumes for these patients
it is recommended that other forms of imaging, such as digital
subtraction angiography (DSA), magnetic resonance angiog-
raphy (MRA), computed tomography angiography (CTA), or
MRI,25, 26 should be obtained according to the clinical practice
of each institution. These other imaging modalities should be
used to establish target volumes and then registered to the CT
scans. Corrections to monitor units can be made if deemed
clinically relevant based on the error estimates shown in
Fig. 8 after image fusion and target transfer.
Several issues exist in mitigating dose calculation uncer-
tainties arising from CT scans of patients with embolization
material. First, care must be used if a water blocked calcula-
tion is considered, as assigning an electron density of water to
the bulk material may well exacerbate the errors in the dose
calculations as shown in Fig. 10 for geometry 4. Secondly,
dose errors in calculations tend to propagate distally from the
edge of the high-density structure. While these dosimetric er-
rors may be large several centimeters from this edge they can
be <2% at or near the embolization material, which is consid-
ered to be near or in the target volume. In this case the actual
volume of the embolization material can be reassigned a bulk
density equal to the surrounding material. If that is not possi-
ble then Fig. 8 can be used to estimate the error in the dose
calculations and monitor units can be recalculated as needed.
A recent publication5 has suggested that for Linac based
radiosurgery low energy components of the therapy beams
could be responsible for under-dosing of target areas in SRS
cases based on Monte Carlo calculations of the peak and mean
energy of a 6 MV Linac.27 Neither the attenuation measure-
ments nor the interface effect results, as described in this pa-
per, support that hypothesis.
This group concluded that embolization material had a
negligible effect on the delivered dose for 60Co treatment from
a Gamma Knife. While 60Co is at a different energy (1.17 and
1.33 MeV) compared to our measurements (6 and 16 MV)
the measurements made in this paper are in qualitative agree-
ment with the previous results for 60C. Figure 8indicates that
dosimetric errors greater than 5% will only occur for effective
embolizing material thickness that are in excess of 8 mm for
a 6 MV beam.
V. CONCLUSIONS
Attenuation effects and interface effects of Onyx on the
delivered dose to the target may be small for MV Linac treat-
ment beams. However, if the effective thickness of the em-
bolization material is greater than 8 mm modifications to
monitor unit calculations may be necessary to properly reflect
the increased attenuation of the Onyx material and assure cor-
rect target dose.
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A potentially large effect of the embolization material on
patient outcome could be due to poor volume delineations
caused by artifacts in, and around, the target volume if a CT
scan is utilized. The high Z doping of the embolization ma-
terial, which is used for visualization during embolization,
causes these artifacts. To establish target volumes for these
patients it is recommended that other forms of imaging be ob-
tained and fused to the planning CT. This allows the target
volumes to be transferred to the CT scans after registration
and thus avoids target delineation errors associated with high
Z CT artifacts. Volumes outside the target area that exhibit
artifacts in the CT scan should have their electron densities
over-ridden to electron densities appropriate to the tissue in
those areas prior to planning.
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